FI960308A0 - Menetelmä Haemophilus influenzae, tyyppi b:n P2-proteiinien ilmentämiseksi ja puhdistamiseksi - Google Patents

Menetelmä Haemophilus influenzae, tyyppi b:n P2-proteiinien ilmentämiseksi ja puhdistamiseksi

Info

Publication number
FI960308A0
FI960308A0 FI960308A FI960308A FI960308A0 FI 960308 A0 FI960308 A0 FI 960308A0 FI 960308 A FI960308 A FI 960308A FI 960308 A FI960308 A FI 960308A FI 960308 A0 FI960308 A0 FI 960308A0
Authority
FI
Finland
Prior art keywords
proteins
purification
expression
type
haemophilus influenzae
Prior art date
Application number
FI960308A
Other languages
English (en)
Swedish (sv)
Other versions
FI960308A (fi
Inventor
Joseph Y Tai
Jeffrey K Pullen
Thomas S Soper
Shu-Mei Liang
Original Assignee
North American Vaccine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North American Vaccine Inc filed Critical North American Vaccine Inc
Publication of FI960308A0 publication Critical patent/FI960308A0/fi
Publication of FI960308A publication Critical patent/FI960308A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10211—Podoviridae
    • C12N2795/10222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI960308A 1993-07-23 1996-01-23 Menetelmä Haemophilus influenzae, tyyppi b:n P2-proteiinien ilmentämiseksi ja puhdistamiseksi FI960308A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/096,181 US6153406A (en) 1993-07-23 1993-07-23 Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B
PCT/US1994/008326 WO1995003069A1 (en) 1993-07-23 1994-07-22 Method for expression and purification of p2 protein from haemophilus influenzae type b

Publications (2)

Publication Number Publication Date
FI960308A0 true FI960308A0 (fi) 1996-01-23
FI960308A FI960308A (fi) 1996-03-22

Family

ID=22256123

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960308A FI960308A (fi) 1993-07-23 1996-01-23 Menetelmä Haemophilus influenzae, tyyppi b:n P2-proteiinien ilmentämiseksi ja puhdistamiseksi

Country Status (11)

Country Link
US (1) US6153406A (fi)
EP (1) EP0724455A4 (fi)
JP (1) JPH09500537A (fi)
AU (1) AU698458B2 (fi)
BR (1) BR9407144A (fi)
CA (1) CA2167808A1 (fi)
FI (1) FI960308A (fi)
NO (1) NO960255L (fi)
NZ (1) NZ271500A (fi)
PL (1) PL181695B1 (fi)
WO (1) WO1995003069A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
US6033877A (en) * 1995-11-02 2000-03-07 Research Foundation Of State University Of New York Peptide expression and delivery system
FR2748476B1 (fr) * 1996-05-07 1998-08-14 Pf Medicament Complexe immunogene, son utilisation, son procede de preparation et vaccin le contenant
CA2297072A1 (en) * 1997-07-17 1999-01-28 North American Vaccine, Inc. Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide
US7785609B1 (en) 1999-03-16 2010-08-31 Sanofi Pasteur Limited Recombinant Haemophilus influenzae adhesin proteins
DE19939246A1 (de) * 1999-08-19 2001-02-22 Phasys Gmbh M Rückfaltung von Membranproteinen
EP1270577B1 (en) * 2000-03-23 2006-12-06 Takeda Pharmaceutical Company Limited Furoisoquinoline derivatives, process for producing the same and use thereof
FR2801219A1 (fr) * 2000-09-18 2001-05-25 Pf Medicament Procede de preparation de proteine recombinante renaturee en presence de detergent
BRPI0924068A2 (pt) * 2008-12-25 2016-07-26 Chemo Sero Therapeut Res Inst vacina recombinante contra coriza infecciosa das aves e processo para preparação da mesma
GB201009861D0 (en) * 2010-06-11 2010-07-21 Novartis Ag OMV vaccines

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4455296A (en) * 1982-02-02 1984-06-19 Board Of Regents, The University Of Texas System Hybrid cell lines producing monoclonal antibodies directed against Haemophilus influenzae
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
US4695624A (en) * 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4656255A (en) * 1985-09-09 1987-04-07 International Minerals & Chemical Corp. Protein recovery
US5173294A (en) * 1986-11-18 1992-12-22 Research Foundation Of State University Of New York Dna probe for the identification of haemophilus influenzae
US5196338A (en) * 1986-12-31 1993-03-23 Praxis Biologics, Inc. Recombinant vectors for Haemophilus influenzae peptides and proteins
AU623353B2 (en) * 1987-12-10 1992-05-14 Board Of Regents, The University Of Texas System Methods and compositions for the production of haemophilus influenzae type b major outer membrane protein antigens
US5192540A (en) * 1988-04-19 1993-03-09 American Cyanamid Company Haemophilus influenzae type b oxidized polysaccharide-outer membrane protein conjugate vaccine
EP0449958B9 (en) * 1988-12-19 2003-05-28 American Cyanamid Company Meningococcal class 1 outer-membrane protein vaccine
GB8830124D0 (en) * 1988-12-23 1989-02-22 Connaught Lab Membrane proteins and peptides of haemophilus influenzae b
CA2006587C (en) * 1988-12-23 2000-01-18 Robert W. Tolan Membrane proteins and peptides of haemophilus influenzae type b
GB8912330D0 (en) * 1989-05-30 1989-07-12 Wellcome Found Live vaccines
DK0504202T3 (da) * 1989-12-14 1995-10-02 Ca Nat Research Council Forbedret meningokok-polysaccharid-konjugat vaccine
SE466259B (sv) * 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
FI903414A (fi) * 1990-07-06 1992-01-07 Kansanterveyslaitos Produktion av proteiner i grampositiva bakterier.
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5503992A (en) * 1993-09-07 1996-04-02 Washington University DNA encoding the 15kD outer membrane protein of Haemophilus influenzae
US5866135A (en) * 1994-04-21 1999-02-02 North American Vaccine, Inc. Group A streptococcal polysaccharide immunogenic compositions and methods
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis

Also Published As

Publication number Publication date
EP0724455A1 (en) 1996-08-07
AU698458B2 (en) 1998-10-29
NO960255D0 (no) 1996-01-22
JPH09500537A (ja) 1997-01-21
BR9407144A (pt) 1996-09-17
PL312700A1 (en) 1996-05-13
FI960308A (fi) 1996-03-22
US6153406A (en) 2000-11-28
PL181695B1 (pl) 2001-09-28
NO960255L (no) 1996-03-22
AU7514494A (en) 1995-02-20
CA2167808A1 (en) 1995-02-02
WO1995003069A1 (en) 1995-02-02
EP0724455A4 (en) 1998-02-04
NZ271500A (en) 1997-11-24

Similar Documents

Publication Publication Date Title
FI942419A (fi) Menetelmä alfa-interferonin valmistamiseksi ja puhdistamiseksi
ATE210142T1 (de) Verfahren zur isolierung und reinigung von 2'- deoxy-2',2'-difluornucleosiden
KR960704082A (ko) 저 잔자성 재료로 이루어진 하나이상의 부재의 처리방법(Method to process at least one member of low-retentivity)
FI953883A (fi) Menetelmä maitohapon erottamiseksi ja puhdistamiseksi
FI962344A (fi) Järjestelmä ja menetelmä selluloosan sisäänruiskuttamiseksi
IL91500A0 (en) Protein of paramyxovirus,method for the production thereof and vaccine containing the same
PL315914A1 (en) Haemopoesive protein as well as method of and materials for obtaining same
FI893542A (fi) Entsyymielektrodit ja menetelmä niiden valmistamiseksi
HUP9900422A3 (en) Novel protein and methods for the production of the same
EP0725145A4 (en) PROTEIN MODIFICATION PROCESS
FI961250A (fi) Puhdistettuja Rhizoctonian neutraalin pH:n lakkaaseja ja näitä koodaavia nukleiinihappoja
ATE206158T1 (de) Verfahren zur herstellung von gereinigtem enzym
FI960308A0 (fi) Menetelmä Haemophilus influenzae, tyyppi b:n P2-proteiinien ilmentämiseksi ja puhdistamiseksi
DK0789767T3 (da) Fremgangsmåde til fremstilling af oprensede papilomavirusproteiner
KR890701577A (ko) 시토칼라신 정제법 및 조성물
FI96317C (fi) Menetelmä hienojakoisten ja muunnettujen tärkkelyksien valmistamiseksi
ZA868274B (en) Purification method for proteins
AU8030391A (en) Method for purification of amino acids, nucleic acids or derivatives thereof
FI960706A (fi) Uusi proteiini ja menetelmiä proteiinin valmistamiseksi
HUT68522A (en) Antimicrobial proteins, preparations containing these proteins, and method for production of them
FI940403A (fi) Elliptisiinijohdannainen ja menetelmä sen valmistamiseksi
FR2701953B1 (fr) Protéine de fusion multi-VIP et procédé de préparation de VIP recombinant.
IL114594A0 (en) Method for extra-cellular expression of protein
DE69322773T2 (de) Haemophilus somnus immunogene proteine
DK75393D0 (da) Production of protein

Legal Events

Date Code Title Description
FD Application lapsed

Free format text: SANDVIK INTELLECTUAL PROPERTY HANDELSBOLAG